Dementia Discovery Fund
Lilly and WHO Foundation partner to support global dementia action plan
The partnership will provide financial support and strengthen early detection and intervention efforts
Breakthrough Alzheimer’s Therapies Drive Early Detection Rates While Exposing Deep Treatment Disparities
Analysis from Komodo Health and Medscape Education shows cognitive screening up 10% and biomarker testing up 23%, yet significant disparities persist in detection for women and treatment access for Black...
Lilly launches global Alzheimer’s campaign with Julianne Moore
The new ‘Brain Health Matters’ campaign urges the public to prioritise brain health
AbbVie and ADARx enter multi-billion dollar partnership to develop siRNA therapies
The companies will focus on developing therapeutics across neuroscience, immunology and oncology
GSK to explore link between Shingrix and dementia risk in new UK research collaboration
More than 55 million people worldwide are currently living with the neurodegenerative disease
UK drug repurposing study identifies several potential dementia treatments
An estimated 982,000 people in the UK are currently living with the neurodegenerative disease
J&J expands neuroscience capabilities with $14.6bn Intra-Cellular acquisition
The deal gives the company access to a range of central nervous system disorder drugs
Novartis and Schrödinger to advance drug candidates in deal worth over $2.4bn
The companies will advance therapeutics for undisclosed targets in Novartis’ core areas
AbbVie to expand neuroscience pipeline with $1.4bn Aliada Therapeutics acquisition
The deal includes a candidate in phase 1 development for Alzheimer's disease
Eli Lilly shares positive results for modified titration of Alzheimer’s drug donanemab
The neurodegenerative disorder accounts for up to 75% of the 982,000 dementia cases in the UK
Astellas and AviadoBio enter exclusive dementia gene therapy deal worth over $2bn
Frontotemporal dementia accounts for less than one in 30 cases of the neurodegenerative disorder
Bayer and NextRNA Therapeutics enter oncology partnership worth $547m
The companies will advance small molecule therapeutics against a new class of targets for cancer